Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation
Despite conventional treatment options including chemoradiation, patients with the most aggressive primary brain tumor, glioblastoma multiforme (GBM), experience an average survival time of less than 15 months. Regarding the malignant nature of GBM, extensive research and discovery of novel treatmen...
Main Authors: | Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, Samaneh Aminyavari, Hossein Javid, Hamid Mollazadeh, Bahram Bibak, Elmira Mohtashami, Tannaz Jamialahmadi, Amir R. Afshari, Amirhossein Sahebkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222011295 |
Similar Items
-
Ferula gummosa gum exerts cytotoxic effects against human malignant glioblastoma multiforme in vitro
by: Amir R. Afshari, et al.
Published: (2022-01-01) -
Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018-09-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Practice Patterns for Managing Recurrent Glioblastoma Multiforme
by: Jitin Bajaj, et al.
Published: (2024-03-01)